Efficacy Study Exploring the Effect of Lu AE58054 as Augmentation Therapy in Patients With Schizophrenia
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to explore the efficacy, safety and cognitive properties of Lu
AE58054 as augmentation therapy to risperidone in patients with schizophrenia.